Serum UA may contribute to vascular stiffness through mechanisms such as inducing the production of C-reactive protein (CRP) in vascular endothelial and smooth muscle cells, thereby stimulating cell proliferation [55] and activating inflammatory pathways that promote collagen production and lead to the development of arteriosclerosis [56]. The gene discussed is CRP; the disease is arteriosclerosis disorder.